Envestnet Asset Management Inc. lifted its stake in shares of Fresenius Medical Care Corporation (NYSE:FMS) by 81.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 261,126 shares of the company’s stock after acquiring an additional 116,987 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Fresenius Medical Care were worth $12,765,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently bought and sold shares of FMS. Harding Loevner LP boosted its stake in Fresenius Medical Care by 4,271.1% in the third quarter. Harding Loevner LP now owns 163,837,558 shares of the company’s stock valued at $31,245,000 after acquiring an additional 160,089,385 shares in the last quarter. Cambiar Investors LLC boosted its stake in shares of Fresenius Medical Care by 3.8% during the third quarter. Cambiar Investors LLC now owns 2,695,714 shares of the company’s stock worth $131,793,000 after buying an additional 99,234 shares during the period. Royal Bank of Canada boosted its stake in shares of Fresenius Medical Care by 6.4% during the second quarter. Royal Bank of Canada now owns 501,694 shares of the company’s stock worth $24,248,000 after buying an additional 30,119 shares during the period. Parametric Portfolio Associates LLC lifted its position in Fresenius Medical Care by 8.2% in the second quarter. Parametric Portfolio Associates LLC now owns 399,706 shares of the company’s stock valued at $19,318,000 after purchasing an additional 30,140 shares during the period. Finally, Jarislowsky Fraser Ltd lifted its position in Fresenius Medical Care by 1.2% in the third quarter. Jarislowsky Fraser Ltd now owns 294,871 shares of the company’s stock valued at $14,416,000 after purchasing an additional 3,556 shares during the period. 3.03% of the stock is currently owned by institutional investors and hedge funds.
Fresenius Medical Care Corporation (FMS) opened at $51.00 on Thursday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.98 and a current ratio of 1.22. Fresenius Medical Care Corporation has a 12 month low of $39.46 and a 12 month high of $51.54. The firm has a market cap of $31,229.42, a P/E ratio of 22.74, a PEG ratio of 2.28 and a beta of 0.45.
A number of brokerages recently commented on FMS. Zacks Investment Research downgraded shares of Fresenius Medical Care from a “hold” rating to a “sell” rating in a research report on Tuesday, October 3rd. DZ Bank reaffirmed a “buy” rating on shares of Fresenius Medical Care in a report on Monday, November 13th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $44.00 target price on shares of Fresenius Medical Care in a report on Wednesday, September 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $48.50.
TRADEMARK VIOLATION WARNING: “Envestnet Asset Management Inc. Buys 116,987 Shares of Fresenius Medical Care Corporation (FMS)” was originally reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.thelincolnianonline.com/2017/12/07/envestnet-asset-management-inc-buys-116987-shares-of-fresenius-medical-care-corporation-fms.html.
Fresenius Medical Care Profile
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.